OVERVIEW
This satellite symposium will provide clinicians with an immersive, case-based educational experience to improve the recognition of basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC) with high-risk features and appropriate management strategies. A simulated waiting room will feature 3 diverse patients with nonmelanoma skin cancers, each experiencing their condition in a different way. A member of the faculty will introduce the case in the lead-up to questions about assessment, diagnosis, and treatment selection that will be answered on interactive iPads. Attendees will be able to interact with clinical decisions throughout the presentation. The faculty panel will provide a case summary and review the latest data in BCC and CSCC to drive clinical decision-making.
GOAL STATEMENT
The goal of this activity is to educate healthcare providers on treatment options for patients with high-risk or advanced nonmelanoma skin cancers.
LEARNING OBJECTIVES
Upon completion of this activity, participants will: Have increased knowledge regarding the [list][item]Current clinical evidence for immunotherapy-based treatment of advanced BCC or CSCC [/list]Have greater competence related to [list][item]Identifying patients are at high risk for BCC or CSCC [item]Determining if a patient with CSCC is a candidate for surgery [/list] [/list]Demonstrate greater confidence in their ability to [list][item]Refer patients with advanced BCC or CSCC to oncology care [/list]
JW Marriott Tampa Water Street
ROOM: HB Plant Ballroom F
510 Water Street
Tampa, FL, 33602
United States
This program is independent and is not part of the official AAD Summer Meeting, as planned by its Scientific Assembly Committee. This program does not qualify for Continuing Medical Education (CME) Credit.
Supported by an independent educational grant from [bold]Regeneron Pharmaceuticals, Inc and Sanofi Genzyme[/bold]